Business & Regulation

What are the consequences of allowing patients to purchase cell and gene therapies directly from hospitals?

Healthcare, fake medicines, and the need for new antibiotics – a round-up from the UK East Africa Health Summit.

Social responsibility at its finest, AI partnerships, and a crack down on vaccine manufacturing malpractice... What’s new for pharma in business?

Sitting Down With… Jinling Chen, Vice President, Pharmaceutical Development Services, WuXi STA, China.

Blockchain could be one solution to the saleable returns verification aspect of the US’ Drug Supply Chain Security Act.

There are few things more inspirational than someone making a positive difference without the need for recognition – but you have to find them first.

We are delighted to announce that The Medicine Maker Power List 2019 is here!

The evolving Brexit landscape provides ample opportunities for companies to position themselves as leaders and influencers.

We present a straightforward guide to preparing papers and posters that will get you noticed.

Oncologists frequently receive “gifts” from pharma companies, but how much is too much?